Invention Grant
- Patent Title: Methods for treating attention deficit hyperactivity disorder
-
Application No.: US15284826Application Date: 2016-10-04
-
Publication No.: US09907803B2Publication Date: 2018-03-06
- Inventor: Laxminarayan Bhat
- Applicant: REVIVA PHARMACEUTICALS, INC.
- Applicant Address: US CA Sunnyvale
- Assignee: REVIVA PHARMACEUTICALS, INC.
- Current Assignee: REVIVA PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Sunnyvale
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/496 ; A61K31/535 ; A61K31/5355 ; A61K31/538
Abstract:
The present invention provides a method of using arylpiperazine derivatives for treating attention deficit hyperactivity disorder (ADHD). The method comprises a step of administering to a patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.
Public/Granted literature
- US20170035772A1 METHODS FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER Public/Granted day:2017-02-09
Information query
